References
- Mango D, Scirpa P, Battaglia F, Tartaglia E, Manna P. Diagnostic significance of steroid hormones in patients with ovarian cancer. J Endocrinol Invest 1988; 93: 07–14
- Scott J S, Lumsden C E, Levell M J. Ovarian endocrine activity in association with hormonally inactive neoplasia. Am J Obstet Gynecol 1997; 97: 161–70
- Scirpa P, Mango D, Battaglia F, Scirpa S, Montemurro A. Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. Maturitas 1982; 433–42
- MacDonald P C, Grodin J M, Edman C D, Vellios F, Siiteri P K. Origin of estrogen in a post-menopausal woman with non-endocrine tumor of the ovary and en-dometrial hyperplasia. Obstet Gynecol 1976; 47: 644–50
- Poliak A, Jones G E, Goldberg B. Effect of human cho-rionic gonadotropin on postmenopausal women. Am J Obstet Gynecol 1968; 101: 731–9
- Greenblatt R B, Colle M L, Mahesh V B. Ovarian and adrenal steroid production in postmenopausal women. Obstet Gynecol 1976; 47: 383–7
- Dennefors B L, Janson P C, Knutson F. Steroid production and responsiveness to gonadotropin in isolated stromal tissue of human postmenopausal ovaries. Am J Obstet Gynecol 1980; 136: 997–1002
- Parker C R, Bruneteau D W, Greenblatt R B, Mahesh V B. Peripheral ovarian and adrenal vein steroids in hirsute women: acute effects of human chorionic gonadotropin and adrenocorticotropic hormone. Fertil Steril 1975; 26: 877–88
- Aiman J, Nalick R H, Jacobs A, Porte J C, Edman C D, Vellios F, MacDonald P C. The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas. Obstet Gynecol 1977; 49: 695–704
- Rome R M, Fortune D W, Quinn M A, Brown J B. Functioning ovarian tumors in postmenopausal women. Obstet Gynecol 1981; 57: 705–10
- Jeppsson S, Kullander S, Rannevik G. Peripheral and ovarian venous concentration of gonadal steroid and CEA in women with ovarian tumors. Acta Obstet Gynecol Scand 1982; 61: 209–12
- Heinonen P K, Tumala R, Pyykkö K, Pystynen P. Peripheral venous concentration of oestrogens in postmenopausal women with ovarian cancer. Br J Obstet Gynecol 1982; 89: 84–6
- Bäckström T, Mählck C G, Kjellgren O. Progesterone as a possible tumor marker for nonendocrine ovarian malignant tumors. Gynecol Oncol 1983; 16: 129–38
- Novak D J, Lauchlan S T, McCawley L C, Faiman C. Virilization during pregnancy. Am J Med 1970; 49: 281–90
- Kammerman S, Demopoulos R I, Raphael C, Ross J. Gonadotrophic hormone binding to human ovarian tumor. Human Pathology 1981; 12: 886–90
- Stanhope C, Smith J, Britton C. Serial determinations of marker substances in ovarian cancer. Gynecol Oncol 1979; 8: 284–7
- Kurman R J, Scully R E. Ovarian tumors, a review. Am J Pathol 1977; 87: 712–20, quoted in
- Quinn M A, Baker H WG, Rome R, Fortune D, Brown J B. Response of a mucinous ovarian tumor of borderline malignancy to human chorionic gonadotropin. Obstet Gynecol 1983; 61: 121–6